Press Releases
Mind Matters

Press Releases

A Statement of Unity

American Brain Tumor Association (ABTA) today announced a new partnership with the Southeastern Brain Tumor Foundation (SBTF) to accelerate brain tumor research. Through this partnership, the Southeastern Brain Tumor Foundation will invest $50,000 in the ABTA research program to fund one glioblastoma immunotherapy research project.

Read More »

American Brain Tumor Association and Southeastern Brain Tumor Foundation Announce Partnership to Accelerate Brain Tumor Research

American Brain Tumor Association (ABTA) today announced a new partnership with the Southeastern Brain Tumor Foundation (SBTF) to accelerate brain tumor research. Through this partnership, the Southeastern Brain Tumor Foundation will invest $50,000 in the ABTA research program to fund one glioblastoma immunotherapy research project.

Read More »

Mind Matters

MindMatters | August 2020

Learn how these ABTA fundraising families have creatively and passionately supported brain tumor research and patient programs through the Fundraise Your Way program.

Read More »

ABTA Announces Recipient of the Joel A. Gingras Award

We are pleased to announce Priscilla Brastianos, MD as the recipient of the ABTA Joel A. Gingras Award for her commitment to the ABTA’s mission through her groundbreaking work and leadership in brain metastasis research. Dr. Brastianos will be awarded the ABTA’s highest honor at the 2020 ABTA National Conference.

Read More »

How Will You BT5K Your Way?

Whether you walk, bike, rollerblade or push a stroller, anyone, anywhere can BT5K Your Way. Get inspired by three participants joining our nationwide event in creative and unique ways that celebrate their family, friends and loved ones impacted by a brain tumor diagnosis.

Read More »
 

Please make sure your info is correct before clicking “Opt me in!”

*Name:



*
 

If you respond and have not already registered, you will receive periodic updates and communications from American Brain Tumor Association.

 

What’s this?







 Please leave this field empty